Liu Jieke, Yang Xi, Li Yong, Xu Hao, He Changjiu, Zhou Peng, Qing Haomiao
Department of Radiology, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610041, China.
Diagnostics (Basel). 2024 Jan 8;14(2):147. doi: 10.3390/diagnostics14020147.
The nodule diameter was commonly used to predict the invasiveness of pulmonary adenocarcinomas in pure ground-glass nodules (pGGNs). However, the diagnostic performance and optimal cut-off values were inconsistent. We conducted a meta-analysis to evaluate the diagnostic performance of the nodule diameter for predicting the invasiveness of pulmonary adenocarcinomas in pGGNs and validated the cut-off value of the diameter in an independent cohort. Relevant studies were searched through PubMed, MEDLINE, Embase, and the Cochrane Library, from inception until December 2022. The inclusion criteria comprised studies that evaluated the diagnostic accuracy of the nodule diameter to differentiate invasive adenocarcinomas (IAs) from non-invasive adenocarcinomas (non-IAs) in pGGNs. A bivariate mixed-effects regression model was used to obtain the diagnostic performance. Meta-regression analysis was performed to explore the heterogeneity. An independent sample of 220 pGGNs (82 IAs and 128 non-IAs) was enrolled as the validation cohort to evaluate the performance of the cut-off values. This meta-analysis finally included 16 studies and 2564 pGGNs (761 IAs and 1803 non-IAs). The pooled area under the curve, the sensitivity, and the specificity were 0.85 (95% confidence interval (CI), 0.82-0.88), 0.82 (95% CI, 0.78-0.86), and 0.73 (95% CI, 0.67-0.78). The diagnostic performance was affected by the measure of the diameter, the reconstruction matrix, and patient selection bias. Using the prespecified cut-off value of 10.4 mm for the mean diameter and 13.2 mm for the maximal diameter, the mean diameter showed higher sensitivity than the maximal diameter in the validation cohort (0.85 vs. 0.72, < 0.01), while there was no significant difference in specificity (0.83 vs. 0.86, = 0.13). The nodule diameter had adequate diagnostic performance in differentiating IAs from non-IAs in pGGNs and could be replicated in a validation cohort. The mean diameter with a cut-off value of 10.4 mm was recommended.
结节直径常用于预测纯磨玻璃结节(pGGNs)型肺腺癌的侵袭性。然而,其诊断性能和最佳临界值并不一致。我们进行了一项荟萃分析,以评估结节直径对预测pGGNs型肺腺癌侵袭性的诊断性能,并在一个独立队列中验证直径的临界值。通过PubMed、MEDLINE、Embase和Cochrane图书馆检索从创刊至2022年12月的相关研究。纳入标准包括评估结节直径区分pGGNs型侵袭性腺癌(IAs)与非侵袭性腺癌(非IAs)诊断准确性的研究。采用双变量混合效应回归模型获得诊断性能。进行Meta回归分析以探索异质性。选取220个pGGNs(82个IAs和128个非IAs)的独立样本作为验证队列,以评估临界值的性能。该荟萃分析最终纳入16项研究和2564个pGGNs(761个IAs和1803个非IAs)。汇总曲线下面积、敏感性和特异性分别为0.85(95%置信区间(CI),0.82 - 0.88)、0.82(95%CI,0.78 - 0.86)和0.73(95%CI,0.67 - 0.78)。诊断性能受直径测量方法、重建矩阵和患者选择偏倚的影响。在验证队列中,使用预先设定的平均直径临界值10.4mm和最大直径临界值13.2mm时,平均直径的敏感性高于最大直径(0.85对0.72,<0.01),而特异性无显著差异(0.83对0.86,=0.13)。结节直径在区分pGGNs型IAs与非IAs方面具有足够的诊断性能,且可在验证队列中重复。推荐平均直径临界值为10.4mm。